STROKE-MALIGNANT MCA INFARCTION

From NeuroRehab.wiki

Revision as of 03:41, 21 February 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SUMMARY

1. Malignant middle cerebral artery (MCA) infarction is a life-threatening form of cerebrovascular accident where the area supplied by the MCA is completely infarcted.

2. It occurs in up to 10% of all stroke patients[1].

3. Patients suffering from malignant MCA infarction usually present clinically with severe hemispheric stroke syndrome including hemiplegia, forced eye and head deviation and progressive deterioration of consciousness within the first 2 days.

4. Symptoms of transtentorial herniation can then occur within 2 to 4 days after the onset of the stroke. This presentation is then followed by early CT signs of major infarcts during the first 12 hours after the stroke[2].

5. The prognosis is extremely poor and the mortality rate for patients who undergo conservative management can be as high as 80%[3].

6. The treatment of malignant MCA is targeted towards decreasing the ICP which is raised as a result of the infarction: conservative medical management vs. surgical decompression.


Reference(s)

  1. Moulin DE, Lo R, Chiang J, Barrett HJM. Prognosis in middle cerebral artery occlusion. Stroke. 1985. 16: 282 – 284.
  2. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. Malignant middle cerebral artery infarction: Clinical course and prognostic signs. Arch Neurol. 1996. 53: 309 – 315.
  3. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. Malignant middle cerebral artery infarction: Clinical course and prognostic signs. Arch Neurol. 1996. 53: 309 – 315.


Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].